Další formáty:
BibTeX
LaTeX
RIS
@misc{1806757, author = {Demlová, Regina}, address = {Brno}, keywords = {Sequential FDG-PET; Plasma/Tissue miRNA; GastroPET; clinical trial; report}, language = {eng}, location = {Brno}, note = {GastroPET}, publisher = {MOÚ}, title = {DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021}, url = {https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001264-38/CZ}, year = {2021} }
TY - GEN ID - 1806757 AU - Demlová, Regina PY - 2021 TI - DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021 VL - NA PB - MOÚ CY - Brno N1 - GastroPET KW - Sequential FDG-PET KW - Plasma/Tissue miRNA KW - GastroPET KW - clinical trial KW - report UR - https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-001264-38/CZ N2 - Clinical Trial GastroPET EudraCT: 2017-001264-38 The clinical trial interim report describes the course and current status of the clinical trial (KH) in a defined period. It includes information on document updates, changes in KH centers and examiners, an overview of previously included/completed subjects of evaluation, and detected protocol violations. It also contains information on investigational medicine (reporting serious adverse events, suspicions of serious (unexpected) adverse events, or new findings in relation to safety and efficacy), new measures taken, and audits performed. ER -
DEMLOVÁ, Regina. \textit{DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021}. Brno: MOÚ, 2021, 3 s. NA.
|